| Announce Date | 11/05/2025 |
| EPS Normalized Actual | $1.05 (Beat by $0.24) |
| EPS GAAP Actual | $1.05 (Beat by $0.24) |
| Revenue Actual | $0.118979B |
| Revenue Surprise | Beat by $118.979M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $0.84333 |
| EPS GAAP Estimate | $0.84333 |
| Revenue Estimate | $0.114173333B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2028 | 0 | INF | 0 | 0 | 1 |
| Dec 2027 | 0 | INF | 0 | 0 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 1.16 | 0.42 | 0.118979B | -32.41% | 18.68M |
| FQ2 2025 (Jun 2025) | 0.81 | 0.07 | 0.116634B | -39.91% | 16.33M |
| FQ1 2025 (Mar 2025) | 0.81 | 0.11 | 0.106436B | 8.81% | 7.74M |
| FQ4 2024 (Dec 2024) | 0.59 | -0.1 | 0.093667B | -3.69% | -3.88M |
| FQ3 2024 (Sep 2024) | 0.7 | 0.065 | 0.157535B | 35.43% | 61.39M |
| FQ2 2024 (Jun 2024) | 0.73 | -0.61259 | 0.163183B | 100% | -48.01M |
| FQ1 2024 (Mar 2024) | 0.69 | 0.69 | 0.097058B | 100% | 97.06M |
| FQ1 2014 (Mar 2014) | -2.42 | -2.42 | 0.051236B | 100% | 51.24M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
0.84333
Consensus Revenue Estimates
0.114173333B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Dec 2026) | 0.98667 | -- | 0.95576 | 1.02459 | 1 |
| FQ3 2026 (Sep 2026) | 0.93 | -24.73 | 0.87819 | 0.99104 | 1 |
| FQ2 2026 (Jun 2026) | 0.87 | 6.9 | 0.82154 | 0.9271 | 1 |
| FQ1 2026 (Mar 2026) | 0.84333 | 3.95 | 0.81691 | 0.87574 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Dec 2026) | 0.13B | -- | 0.12B | 0.13B | 1 |
| FQ3 2026 (Sep 2026) | 0.12B | -1.6 | 0.11B | 0.12B | 2 |
| FQ2 2026 (Jun 2026) | 0.11B | -2.4 | 0.11B | 0.12B | 2 |
| FQ1 2026 (Mar 2026) | 0.11B | 6.78 | 0.11B | 0.12B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
5
EPS # of Misses
3
EPS # of in-lines
0
Revenue # of Beats
6
Revenue # of Misses
2
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.74 | 1.16 | 0.42 | 36.21% |
| FQ2 2025 (Jun 2025) | 0.74 | 0.81 | 0.07 | 8.64% |
| FQ1 2025 (Mar 2025) | 0.7 | 0.81 | 0.11 | 13.58% |
| FQ4 2024 (Dec 2024) | 0.69 | 0.59 | -0.1 | -16.95% |
| FQ3 2024 (Sep 2024) | 0.635 | 0.7 | 0.065 | 9.29% |
| FQ2 2024 (Jun 2024) | 1.34259 | 0.73 | -0.61259 | -83.92% |
| FQ1 2024 (Mar 2024) | 0.69 | 0.69 | 100% | |
| FQ1 2014 (Mar 2014) | -2.42 | -2.42 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0.1B | $0.12B | $18.68M | 15.7% |
| FQ2 2025 (Jun 2025) | $0.1B | $0.12B | $16.33M | 14% |
| FQ1 2025 (Mar 2025) | $0.1B | $0.11B | $7.74M | 7.27% |
| FQ4 2024 (Dec 2024) | $0.1B | $0.09B | $-3.88M | -4.15% |
| FQ3 2024 (Sep 2024) | $0.1B | $0.16B | $61.39M | 38.97% |
| FQ2 2024 (Jun 2024) | $0.21B | $0.16B | $-48.01M | -29.42% |
| FQ1 2024 (Mar 2024) | $0B | $0.1B | $97.06M | 100% |
| FQ1 2014 (Mar 2014) | $0B | $0.05B | $51.24M | 100% |